Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection COVID-19 and PRES
International Clinical Neuroscience Journal,
Vol. 8 No. 3 (2021),
30 June 2021
Neurological complications of COVID-19 are well documented. However, there are limited reports of posterior reversible encephalopathy syndrome (PRES) associated with COVID-19 in the literature. Herein, we described a 21-year-old man with a history of bipolar disease and opioid addiction who was admitted because of COVID-19 infection. He suddenly experienced a convulsive status epilepticus following hypertension crisis. The patient was intubated and underwent antiepileptic and anti-hypertensive therapy. His brain imaging was compatible with PRES. The patient gradually improved and was eventually discharged after 40 days. On the next month follow-up, the patient was able to walk with a cane without a history of seizure. In this report, we aimed to highlight the less common cerebrovascular complication of COVID-19 infection.
- Posterior reversible encephalopathy syndrome; Encephalopathy; COVID-19.
How to Cite
Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med. 2020;9(3). doi: 10.3390/jcm9030623.
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552-5. doi: 10.1002/jmv.25728.
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv. 2020. doi: 10.1101/2020.02.22.20026500.
Sabayan B, Moghadami M, Assarzadegan F, Komachali SH, Poorsaadat L, Babaeepour Z, et al. COVID-19 respiratory illness and subsequent cerebrovascular events, the initial Iranian experience. J Stroke Cerebrovasc Dis. 2021;30(1):105454. doi: 10.1016/j. jstrokecerebrovasdis.2020.105454.
Khosraviani S, Paybast S, Emami A. Encephalitis as a rare manifestation of novel COVID-19 disease, a para-infection or postinfection complication: a systematic review. Rom J Neurol. 2020;19(3):153-60.
Kaya Y, Kara S, Akinci C, Kocaman AS. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: case report. J Neurol Sci. 2020;413:116858. doi: 10.1016/j.jns.2020.116858.
Coolen T, Lolli V, Sadeghi N, Rovaï A, Trotta N, Taccone FS, et al. Early postmortem brain MRI findings in COVID-19 non-survivors. medRxiv. 2020. doi: 10.1101/2020.05.04.20090316.
Legriel S, Pico F, Azoulay E. Understanding posterior reversible encephalopathy syndrome. In: Vincent JL, ed. Annual Update in Intensive Care and Emergency Medicine 2011. Berlin: Springer; 2011. p. 631-53. doi: 10.1007/978-3- 642-18081-1_56.
Hefzy HM, Bartynski WS, Boardman JF, Lacomis D. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30(7):1371-9. doi: 10.3174/ajnr.A1588.
Agarwal S, Conway J, Nguyen V, Dogra S, Krieger P, Zagzag D, et al. Serial imaging of virus-associated necrotizing disseminated acute leukoencephalopathy (VANDAL) in COVID-19. AJNR Am J Neuroradiol. 2021;42(2):279-84. doi: 10.3174/ajnr.A6898.
Mozhdehipanah H, Paybast S, Bahadori R. Posterior reversible encephalopathy syndrome as a rare presentation of coronavirus disease 2019: a case report and literature review. J Vessel Circ. 2020;1(2):11-6. doi: 10.29252/ jvesselcirc.1.2.11.
Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24(1):353. doi: 10.1186/s13054-020-03062-7.
- Abstract Viewed: 111 times
- PDF Downloaded: 75 times